Kymera Therapeutics
KYMR
$37.40
Share price
3.03%
Change (1 day)
21.04%
Change (1 year)
Categories
EPS for Kymera Therapeutics (KYMR)
EPS in 2023 (TTM): -$2.87
According to Kymera Therapeutics's latest financial reports the company's current EPS (TTM) is -$2.87. In 2022 the company made an earnings per share (EPS) of -$2.88 a decrease over its 2021 EPS that were of -$2.06.
EPS history for Kymera Therapeutics from 2020 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$2.87 | -0.35% |
| 2022 | -$2.88 | 39.81% |
| 2021 | -$2.06 | 22.84% |
| 2020 | -$1.68 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$2.18 | -24.04% | 🇺🇸 USA |